Krishna C Vemulapalli1, Douglas K Rex1. 1. Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Abstract
BACKGROUND: The United Kingdom (U.K.) post-adenoma resection guidelines recommend earlier surveillance for patients with 5 or more adenomas or 3 to 4 adenomas of which one is 10 mm or larger compared with U.S. guidelines. OBJECTIVE: To evaluate the effect of using the U.K. guideline on a U.S. cohort of adenoma patients. DESIGN: Single-center, retrospective study. SETTING: Indiana University Hospital and an associated ambulatory surgery center. PATIENTS: A total of 1414 patients with baseline adenoma findings belonging to one of 5 risk categories and with a follow-up colonoscopy more than 200 days later. INTERVENTION: Colonoscopy, polypectomy. MAIN OUTCOME MEASUREMENTS: Incidence of advanced lesions at follow-up colonoscopy. RESULTS: Advanced neoplasms at follow-up occurred in 16.3% of patients with 5 or more adenomas including 1 that was 10 mm or larger, 8.6% of patients with 3 or 4 adenomas including 1 that was 10 mm or larger, 5% of those with 5 or more adenomas all smaller than 10 mm, 1.8% of those with 3 or 4 adenomas all smaller than 10 mm, and 1.4% of those with 1 to 2 adenomas smaller than 10 mm. Logistic regression analyses showed that the rate of advanced lesions at first follow-up was increased in persons with 3 or more baseline adenomas and at least 1 that is 10 mm or larger compared with those with 1 to 4 small baseline adenomas. LIMITATIONS: Single-center, retrospective study. CONCLUSIONS: Our results indicate the U.K. guideline predicts higher risk groups for advanced neoplasia at first follow-up. Our study had inadequate power to show better prediction of incident cancer. Additional study of other databases is warranted.
BACKGROUND: The United Kingdom (U.K.) post-adenoma resection guidelines recommend earlier surveillance for patients with 5 or more adenomas or 3 to 4 adenomas of which one is 10 mm or larger compared with U.S. guidelines. OBJECTIVE: To evaluate the effect of using the U.K. guideline on a U.S. cohort of adenomapatients. DESIGN: Single-center, retrospective study. SETTING: Indiana University Hospital and an associated ambulatory surgery center. PATIENTS: A total of 1414 patients with baseline adenoma findings belonging to one of 5 risk categories and with a follow-up colonoscopy more than 200 days later. INTERVENTION: Colonoscopy, polypectomy. MAIN OUTCOME MEASUREMENTS: Incidence of advanced lesions at follow-up colonoscopy. RESULTS: Advanced neoplasms at follow-up occurred in 16.3% of patients with 5 or more adenomas including 1 that was 10 mm or larger, 8.6% of patients with 3 or 4 adenomas including 1 that was 10 mm or larger, 5% of those with 5 or more adenomas all smaller than 10 mm, 1.8% of those with 3 or 4 adenomas all smaller than 10 mm, and 1.4% of those with 1 to 2 adenomas smaller than 10 mm. Logistic regression analyses showed that the rate of advanced lesions at first follow-up was increased in persons with 3 or more baseline adenomas and at least 1 that is 10 mm or larger compared with those with 1 to 4 small baseline adenomas. LIMITATIONS: Single-center, retrospective study. CONCLUSIONS: Our results indicate the U.K. guideline predicts higher risk groups for advanced neoplasia at first follow-up. Our study had inadequate power to show better prediction of incident cancer. Additional study of other databases is warranted.
Authors: Amy C Degnim; William D Dupont; Derek C Radisky; Robert A Vierkant; Ryan D Frank; Marlene H Frost; Stacey J Winham; Melinda E Sanders; Jeffrey R Smith; David L Page; Tanya L Hoskin; Celine M Vachon; Karthik Ghosh; Tina J Hieken; Lori A Denison; Jodi M Carter; Lynn C Hartmann; Daniel W Visscher Journal: Cancer Date: 2016-06-28 Impact factor: 6.860
Authors: Samir Gupta; David Lieberman; Joseph C Anderson; Carol A Burke; Jason A Dominitz; Tonya Kaltenbach; Douglas J Robertson; Aasma Shaukat; Sapna Syngal; Douglas K Rex Journal: Gastroenterology Date: 2020-02-07 Impact factor: 22.682
Authors: Samir Gupta; David Lieberman; Joseph C Anderson; Carol A Burke; Jason A Dominitz; Tonya Kaltenbach; Douglas J Robertson; Aasma Shaukat; Sapna Syngal; Douglas K Rex Journal: Gastrointest Endosc Date: 2020-02-07 Impact factor: 9.427
Authors: Matthew D Rutter; James East; Colin J Rees; Neil Cripps; James Docherty; Sunil Dolwani; Philip V Kaye; Kevin J Monahan; Marco R Novelli; Andrew Plumb; Brian P Saunders; Siwan Thomas-Gibson; Damian J M Tolan; Sophie Whyte; Stewart Bonnington; Alison Scope; Ruth Wong; Barbara Hibbert; John Marsh; Billie Moores; Amanda Cross; Linda Sharp Journal: Gut Date: 2019-11-27 Impact factor: 31.793
Authors: Samir Gupta; David Lieberman; Joseph C Anderson; Carol A Burke; Jason A Dominitz; Tonya Kaltenbach; Douglas J Robertson; Aasma Shaukat; Sapna Syngal; Douglas K Rex Journal: Am J Gastroenterol Date: 2020-03 Impact factor: 12.045
Authors: Elisabeth Waldmann; Andreas Kammerlander; Irina Gessl; Daniela Penz; Barbara Majcher; Anna Hinterberger; Michael Trauner; Monika Ferlitsch Journal: United European Gastroenterol J Date: 2021-08-03 Impact factor: 4.623